Identification of potent, non-toxic, selective CDK2 inhibitor through the pharmacophore-based scaffold hopping, molecular dynamics simulation-assisted molecular docking study, Lee Richard contour map analysis, and ADMET properties-Reference-Cited by-同舟云学术

Identification of potent, non-toxic, selective CDK2 inhibitor through the pharmacophore-based scaffold hopping, molecular dynamics simulation-assisted molecular docking study, Lee Richard contour map analysis, and ADMET properties

Published:2022-05-07 Issue:6 Volume:33 Page:1895-1905
ISSN:1040-0400
Container-title:Structural Chemistry
language:en
Short-container-title:Struct Chem

Author:

Chaube Udit^ORCID,Bhatt Hardik

Publisher

Springer Science and Business Media LLC

Subject

Physical and Theoretical Chemistry,Condensed Matter Physics

Link

https://link.springer.com/content/pdf/10.1007/s11224-022-01958-4.pdf

Reference22 articles.

1. Chaube UJ, Rawal R, Jha AB, Variya B, Bhatt HG (2021) Design and development of tetrahydro-quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer. Bioorg Chem 106:104501. https://doi.org/10.1016/j.bioorg.2020.104501

2. Ryan JM, Peterson MD, Ryan N et al (2019) Mortality due to cardiovascular disease, respiratory disease, and cancer in adults with cerebral palsy. Dev Med Child Neurol 61:924–928. https://doi.org/10.1111/dmcn.14176

3. Estapé T (2017) Cancer in the elderly: challenges and barriers. Asia Pac J Oncol. https://doi.org/10.4103/apjon.apjon_52_17

4. Cicenas J, Zalyte E, Bairoch A, Gaudet P (2018) Kinases and cancer. Cancers 10:63. https://doi.org/10.3390/cancers10030063

5. Kawakami M, Mustachio LM, Rodriguez CJ et al (2017) Next-generation CDK2/9 inhibitors and anaphase catastrophe in lung cancer. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djw297

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive analysis of the role of molecular docking in the development of anticancer agents against the cell cycle CDK enzyme;BIOCELL;2023